Accepted author manuscript, 458 KB, PDF document
Available under license: CC BY: Creative Commons Attribution 4.0 International License
Final published version
Licence: CC BY: Creative Commons Attribution 4.0 International License
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - A proposal for a new PhD level curriculum on quantitative methods for drug development
AU - Jaki, Thomas Friedrich
AU - Gordon, A
AU - Forster, Pamela Suzanne
AU - Bijnens, L
AU - Bornkamp, B
AU - Brannath, Werner
AU - Fontana, Roberto
AU - Gasparini, Mauro
AU - Hampson, Lisa Victoria
AU - Jacobs, Tom
AU - Jones, Byron
AU - Paoletti, Xavier
AU - Posch, Martin
AU - Titman, Andrew Charles
AU - Vonk, Richardus
AU - Koenig, Franz
PY - 2018/9
Y1 - 2018/9
N2 - This paper provides an overview of “Improving Design, Evaluation and Analysis of early drug development Studies” (IDEAS), a European Commission–funded network bringing together leading academic institutions and small‐ to large‐sized pharmaceutical companies to train a cohort of graduate‐level medical statisticians. The network is composed of a diverse mix of public and private sector partners spread across Europe, which will host 14 early‐stage researchers for 36 months. IDEAS training activities are composed of a well‐rounded mixture of specialist methodological components and generic transferable skills. Particular attention is paid to fostering collaborations between researchers and supervisors, which span academia and the private sector. Within this paper, we review existing medical statistics programmes (MSc and PhD) and highlight the training they provide on skills relevant to drug development. Motivated by this review and our experiences with the IDEAS project, we propose a concept for a joint, harmonised European PhD programme to train statisticians in quantitative methods for drug development.
AB - This paper provides an overview of “Improving Design, Evaluation and Analysis of early drug development Studies” (IDEAS), a European Commission–funded network bringing together leading academic institutions and small‐ to large‐sized pharmaceutical companies to train a cohort of graduate‐level medical statisticians. The network is composed of a diverse mix of public and private sector partners spread across Europe, which will host 14 early‐stage researchers for 36 months. IDEAS training activities are composed of a well‐rounded mixture of specialist methodological components and generic transferable skills. Particular attention is paid to fostering collaborations between researchers and supervisors, which span academia and the private sector. Within this paper, we review existing medical statistics programmes (MSc and PhD) and highlight the training they provide on skills relevant to drug development. Motivated by this review and our experiences with the IDEAS project, we propose a concept for a joint, harmonised European PhD programme to train statisticians in quantitative methods for drug development.
KW - development of early‐stage researchers
KW - drug development
KW - PhD curriculum
KW - regulatory statistics
KW - university‐industry partnership
U2 - 10.1002/pst.1873
DO - 10.1002/pst.1873
M3 - Journal article
VL - 17
SP - 593
EP - 606
JO - Pharmaceutical Statistics
JF - Pharmaceutical Statistics
SN - 1539-1604
IS - 5
ER -